TGFB1 and breast carcinoma: The gene expressions of CDK4, CDK6, TGF-β, and NF-κβ were significantly reduced by abemaciclib in breast cancer cell lines MCF-7 and MDA-MB-231 compared to untreated cells of each cell line.